PRESENTATION TITLE:
Advances in Systemic Therapy for Early-Stage Breast Cancer: Highlights from SABCS 2025

PRESENTER(S):
Matthew P. Goetz, MD, and Karthik V. Giridhar, MD

VIEWING LOCATION:
In-Person Location- Gonda 2-101 Mathy Lecture Hall and virtually on Teams

FOOD / BEVERAGE:
Light breakfast refreshments provided

LEARNING OBJECTIVES
Upon completion of this activity, participants should be able to: 

1. Interpret emerging evidence on biomarkers and genomic assays to refine risk stratification and treatment selection 

2. Integrate updates on systemic therapies (e.g., endocrine therapy, chemotherapy, targeted agents) into individualized treatment plans for early-stage and metastatic HER2-positive and ER-positive/HER2- breast cancer 

3. Assess how recent findings may impact shared decision-making regarding treatment escalation or de-escalation 

ATTENDANCE / CREDIT:
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

To claim credit for livestream participation in this course, learners must view the content during the hours posted for the live activity.  This course is not approved for on-demand delivery. 

TRANSCRIPT:
Any credit or attendance awarded from this session will appear on your Transcript.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.

QUESTIONS?
Contact Sheila Terrill, Education Specialist - GIM CME